Searched for
CARACO PHARMA
Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Sun Pharma arm to buy Takeda's US-based generics subsidiary URL PharmaSun Pharmaceutical Industries today said its arm Caraco Pharma will buy Japanese drug maker Takeda Pharmaceuticals' US-based generics subsi...
- Sun Pharma's Caraco gets USFDA nod to resume drug productionSun Pharmaceutical Industries today said American health regulator has approved resumption of manufacturing operations at its US-based subs...
- Sun Pharmaceutical Industries gets favourable US Supreme Court verdict in patent caseSun Pharma said the US SC has given a favourable verdict in its patent case against Novo Nordisk over generic Prandin tablets used for trea...
- Sun Pharma's US arm resolves issues with health regulatorUSFDA had pulled up the US arm of Sun Pharma for violation of manufacturing standards such lack of consistent quality.
- Pharma major, Sun, back on growth trackAfter facing a regulatory clampdown by the US FDA in 2009, Caraco has had its manufacturing suspended. It now sells distributed products.
- Sun Pharma plans to delist Caraco, offers share buybackSun Pharma said it plans to delist its Detroit-based subsidiary Caraco Pharma from the US bourses by acquiring all the shares of it.
- Caraco may shift production to IndiaSun Pharmaceutical Industries' US-based subsidiary Caraco, which is facing a Food and Drug Administration ban on manufacturing, is looking ...
- Taro drags Sun to court againSun Pharmaceuticals has been slapped with another lawsuit. The Mumbai-based pharma company has been sued by Taro Pharmaceuticals, the Israe...
- Sun Pharma plunges 8 pc on BSEShares of Sun Pharmaceutical plunged nearly eight per cent in the early trade on the Bombay Stock Exchange amid reports that a class action...
- Sun Pharma arm faces class action suit in USLegal experts said US investors could seek damages from companies under US law for losses due to non-disclosure of regulatory investigation...
- Sun Pharma enters pact with Forest Labs,H Lundbeck for LexaproSun Pharma and its US subsidiary Caraco Pharma have entered into agreements with Forest Laboratoriesa and H Lundbeck to settle legal procee...
- Sun Pharma’s US arm cuts 350 jobsSun Pharmaceutical’s US subsidiary, Caraco Pharma, has decided to cut its workforce by more than a half after the recent clampdown by USFDA...
- Sun Pharma's US subsidiary to slash 350 jobs in the USSun Pharma's US subsidiary, Caraco Pharmaceutical Laboratories, on Tuesday said that it is slashing 350 jobs.
- St hammers Sun Pharma as USFDA seizes 33 drugs of armUS authorities seized drugs made by Sun Pharmaceuticals’ US subsidiary for violation of manufacturing standards, pushing down share prices ...
- Drug recall to have minimal impact on SunIndia’s largest drugmaker by market capitalisation Sun Pharma whose US arm recalled one of the products sold in the world’s largest drug ma...
- Regulator issues letter on ManufacturingAfter Ranbaxy, Sun Pharma's USbased subsidiary, Caraco has come under the glare of US Food and Drug Administration (FDA) for certain manufa...
- Sun's US arm gets warning from FDAFDA may withhold approval of pending drug applications of Caraco till the company satisfies the authority’s concerns.
- Sun Pharma subsidiary receives FDA warning letterCaraco Pharmaceuticals, a subsidiary of Sun Pharma, on Tuesday said it has received a warning letter from United States Food and Drug Admin...
Load More- Sun Pharma's Caraco gets USFDA nod to resume drug production
